Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ C6040033!6040033!30013749     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Gastroenterol+Hepatol+Bed+Bench 2018 ; 11 (3): 244-9 Nephropedia Template TP {{tp|p=30013749|t=2018. Prevalence of celiac disease serological markers in a cohort of Italian rheumatological patients |pdf=|usr=}}{{30013749}} gab.com Text Prevalence of celiac disease serological markers in a cohort of Italian rheumatological patients JO: Gastroenterol Hepatol Bed Bench http://www.kidney.de/pget.php?&tw=1&pmid=30013749 #FOAvip Aim:: To assess the prevalence of celiac disease (CD) serological markers in a cohort of patients referred to an Italian rheumatological outpatient clinic. Background:: Current guidelines do not suggest CD screening in patients with rheumatological diseases and these subjects are not considered to be at high risk for CD. Methods:: A total of 230 sera of rheumatological patients referred to the Division of Internal Medicine at the Department of Medical and Surgical Sciences between January 2005 and December 2013 were screened for CD by testing IgA antitransglutaminase (TTG IgA), IgG deamidated gliadin peptides (DGP IgG) and IgA antiendomysium (EMA) antibodies. Of the 230 patients tested, 67 had a diagnosis of rheumatoid arthritis (RA), 52 Sjögren?s syndrome (SjS), 42 systemic sclerosis (SCL), 35 systemic lupus erythematosus (SLE), 15 mixed connective tissue disease, 11 polymyositis and 10 dermatomyositis. Results:: TTG IgA antibodies were identified in 7/230 cases (3%), 3 in SjS (3/42 ? 5.8%), 2 in SCL (2/42 ? 4.8%), 1 in RA (1/67 ? 1.5%) and 1 in SLE sera (1/35 ? 2.8%). All the seven sera were also positive for DGP IgG and EMA IgA. DGP IgG were the most frequent antibody detected, being found in 16 (7%) sera. Conclusion:: This study identified a high prevalence of CD antibodies in adult patients referred to a rheumatology outpatient clinic. These results highlight the importance of CD screening in subjects presenting with rheumatological features. Twit Text FOAVip Prevalence of celiac disease serological markers in a cohort of Italian rheumatological patients ????Gastroenterol Hepatol Bed Bench http://www.kidney.de/pget.php?&tw=1&pmid=30013749 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30013749 #FOAvip English Wikipedia <ref>{{Cite pmid|30013749}}</ref> Prevalence of celiac disease serological markers in a cohort of Italian rheumatological patients #MMPMID30013749 Caio G; De Giorgio R; Ursini F; Fanaro S; Volta U Gastroenterol Hepatol Bed Bench 2018[Sum]; 11 (3): 244-9 PMID30013749show ga Aim:: To assess the prevalence of celiac disease (CD) serological markers in a cohort of patients referred to an Italian rheumatological outpatient clinic. Background:: Current guidelines do not suggest CD screening in patients with rheumatological diseases and these subjects are not considered to be at high risk for CD. Methods:: A total of 230 sera of rheumatological patients referred to the Division of Internal Medicine at the Department of Medical and Surgical Sciences between January 2005 and December 2013 were screened for CD by testing IgA antitransglutaminase (TTG IgA), IgG deamidated gliadin peptides (DGP IgG) and IgA antiendomysium (EMA) antibodies. Of the 230 patients tested, 67 had a diagnosis of rheumatoid arthritis (RA), 52 Sjögren?s syndrome (SjS), 42 systemic sclerosis (SCL), 35 systemic lupus erythematosus (SLE), 15 mixed connective tissue disease, 11 polymyositis and 10 dermatomyositis. Results:: TTG IgA antibodies were identified in 7/230 cases (3%), 3 in SjS (3/42 ? 5.8%), 2 in SCL (2/42 ? 4.8%), 1 in RA (1/67 ? 1.5%) and 1 in SLE sera (1/35 ? 2.8%). All the seven sera were also positive for DGP IgG and EMA IgA. DGP IgG were the most frequent antibody detected, being found in 16 (7%) sera. Conclusion:: This study identified a high prevalence of CD antibodies in adult patients referred to a rheumatology outpatient clinic. These results highlight the importance of CD screening in subjects presenting with rheumatological features. äPrevalence of celiac disease serological markers in a cohort of Italia(epmc).pdf DeepDyve Pubget Overpricing